-
Study aim
-
This study aime to compare the effect of dexamethasone and ketorolac on pain control in elective foot surgery
-
Design
-
After the surgery, the patients were randomly split into two groups of 20 based on a table of random numbers. Patients in the first group received 8 mg of dexamethasone intravenously. Also, for the second group, 90 mg of ketorolac (Caspian Tamin Rasht Company) was infused in 1 liter of normal saline serum within 24 hours. While the patients were not aware of the type of medicine they were receiving (first type blindness). During 24 hours of patient monitoring, postoperative pain evaluation was initially performed at recovery time in 0, 2, 4, and 6 hours after the injection by an unaware intern and by VAS.
-
Settings and conduct
-
This study was a double-blind, randomized clinical trial. Out of a total of 53 patients who referred to Akhtar and Imam hospitals with ASA I and II class in the age group of 20 to 60 years, 40 candidates were selected and were divided into two groups.
-
Participants/Inclusion and exclusion criteria
-
Criteria for entering: being in the age group of 20 to 60 years and a candidate for orthopedic surgery of the lower limbs. Criteria for withdrawal: Pregnant and lactating women with impaired renal function or dialysis, heart disease, contraindications to opioid medications, hemorrhage, especially gastrointestinal hemorrhage, history of high blood pressure, history of anemia and thrombocytopenia, drug addiction, and asthma and lung disease and allergies to NSAID.
-
Intervention groups
-
dexamethasone and ketorolac
Patients in the first group receive 8 mg of dexamethasone intravenously. Also, for the second group, 90 mg of ketorolac (Caspian Tamin Rasht Company) infused in 1 liter of normal saline serum within 24 hours.
-
Main outcome variables
-
pain control